Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105753864B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105753864B reveals a novel Pd-Cu catalyzed synthesis for high-purity antitumor intermediates, offering significant cost reduction and supply chain reliability for global buyers.